---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-046178"
form_type: "8-K"
ticker: "A"
cik: "0001090872"
company_name: "AGILENT TECHNOLOGIES, INC."
filed_at: "2023-09-05T23:59:59+00:00"
generated_at: "2026-06-10T23:44:59.230090+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Agilent names Philip Binns LSAG president after Jacob Thaysen departs

## Summary
- Jacob Thaysen resigned as SVP and president of Life Sciences and Applied Markets Group (LSAG), effective Sept. 5, 2023.
- Philip Binns promoted to LSAG president; previously VP/GM of Spectroscopy and Vacuum Solutions division.
- Binns joined Agilent in 2010 via Varian acquisition and has led the spectroscopy business transformation.
- CEO Mike McMullen thanked Thaysen for his contributions and expressed confidence in Binns.

## SEC filing metadata
- accession: 0000950170-23-046178
- form_type: 8-K
- ticker: A
- cik: 0001090872
- company_name: AGILENT TECHNOLOGIES, INC.
- filed_at: 2023-09-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1090872/000095017023046178/0000950170-23-046178-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1090872/000095017023046178/a-20230901.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-046178
- JSON: https://secwatch.observer/filing/0000950170-23-046178.json
- Plain text: https://secwatch.observer/filing/0000950170-23-046178.txt

## Key facts
- Executive change
  Jacob Thaysen resigned as Senior Vice President, president, Life Sciences and Applied Markets Group at AGILENT TECHNOLOGIES, INC..
  - Action: resigned
  - Role: Senior Vice President, president, Life Sciences and Applied Markets Group
  source text: Jacob Thaysen resigned as Senior Vice President of the Company, and president, Life Sciences and Applied Markets Group (LSAG), effective September 5, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1090872/000095017023046178/0000950170-23-046178-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.